Attenuation of the epidemic increase in non-Hodgkin's lymphomas in Spain

Annals of Oncology

Volumn 21, Issue SUPPL.3, 2010, Pages

  Marcos Gragera, R ^a   Pollan M ^b,d   Chirlaque, M D ^c,d   Guma J ^e   Sanchez, M J ^d,f   Garau, I ^g   Dorronsorro, M ^d   Giraldo, P ^h   Diaz Garcia J M ⁱ   Gutierrez G ⁱ   Rodriguez L ^j   Perez de Rada E ^k  

^a DEPARTMENT OF HEALTH   (Spain)

^b CARLOS III INSTITUTE OF HEALTH   (Spain)

^c Health Authority   (Spain)

^d CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^e INSTITUT D INVESTIGACIÓ SANITÀRIA PERE VIRGILI IISPV   (Spain)

^f ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^g Mallorca Cancer Registry   (Spain)

^h HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

ⁱ Health and Social Welfare Authority   (Spain)

^j Health and Medical Services Authority   (Spain)

^k INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

more..

Author keywords

Change point transition models; Incidence trends; Non Hodgkin's lymphoma; Population based study; Spain

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER CONTROL; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER REGISTRY; CANCER RISK; CHILD; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; EPIDEMIC; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE; SPAIN; TREND STUDY; ADOLESCENT; COMPARATIVE STUDY; HEALTH SURVEY; METHODOLOGY; MIDDLE AGED; NEWBORN; REGISTER;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; EPIDEMICS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; REGISTRIES; SPAIN; YOUNG ADULT;

EID: 78149435695     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq088     Document Type: Article

References (38)

1. Domingo-Domenech E, de Sanjose S, Gonzalez-Barca E et al. Post-transplant lymphomas: a 20-year epidemiologic, clinical and pathologic study in a single center. Haematologica 2001; 86: 715-721.
2. Gallagher B, Wang Z, Schymura MJ et al. Cancer incidence in New York State acquired immunodeficiency syndrome patients. Am J Epidemiol 2001; 154: 544-556.
3. de Sanjose S, Dickie A, Alvaro T et al. Helicobacter pylori and malignant lymphoma in Spain. Cancer Epidemiol Biomarkers Prev 2004; 13: 944-948.
4. de Sanjose S, Nieters A, Goedert JJ et al. Role of hepatitis C virus infection in malignant lymphoma in Spain. Int J Cancer 2004; 111: 81-85.
5. de Sanjose S, Benavente Y, Vajdic CM et al. Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol 2008; 6: 451-458.
6. Kogevinas M, Kauppinen T, Winkelmann R et al. Soft tissue sarcoma and non-Hodgkin's lymphoma in workers exposed to phenoxy herbicides, chlorophenols, and dioxins: two nested case-control studies. Epidemiology 1995; 6: 396-402.
7. van Balen E, Font R, Cavalle N et al. Exposure to non-arsenic pesticides is associated with lymphoma among farmers in Spain. Occup Environ Med 2006; 63: 663-668.
8. Hartge P, Wang SS, Bracci PM et al. Non-Hodgkin-lymphoma. In Schottenfeld D, Fraumeni JF (eds): Cancer Epidemiology and Prevention, 3rd edn. New York, NY: Oxford University Press 2006; 898-918.
9. Curado MP, Edwards B, Shin HR et al. Cancer Incidence in Five Continents, Vol. IX. (IARC Scientific Publications No. 160). Lyon, France: IARC 2007.
10. Cartwright R, Brincker H, Carli PM et al. The rise in incidence of lymphomas in Europe 1985-1992. Eur J Cancer 1999; 35: 627-633.
11. Groves FD, Linet MS, Travis LB, Devesa SS. Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst 2000; 92: 1240-1251.
12. Liu S, Semenciw R, Mao Y. Increasing incidence of non-Hodgkin's lymphoma in Canada, 1970-1996: age-period-cohort analysis. Hematol Oncol 2003; 21: 57-66.
13. Pollan M, Lopez-Abente G, Moreno C et al. Rising incidence of non-Hodgkin's lymphoma in Spain: analysis of period of diagnosis and cohort effects. Cancer Epidemiol Biomarkers Prev 1998; 7: 621-625.
14. Adamson P, Bray F, Costantini AS et al. Time trends in the registration of Hodgkin and non-Hodgkin lymphomas in Europe. Eur J Cancer 2007; 43: 391-401.
15. Fisher SG, Fisher RI. The epidemiology of non-Hodgkin's lymphoma. Oncogene 2004; 23: 6524-6534.
16. Sandin S, Hjalgrim H, Glimelius B et al. Incidence of non-Hodgkin's lymphoma in Sweden, Denmark, and Finland from 1960 through 2003: an epidemic that was. Cancer Epidemiol Biomarkers Prev 2006; 15: 1295-1300.
17. Clarke CA, Undurraga DM, Harasty PJ et al. Changes in cancer registry coding for lymphoma subtypes: reliability over time and relevance for surveillance and study. Cancer Epidemiol Biomarkers Prev 2006; 15: 630-638.
18. McCullagh P, Nelder JA. Generalized Linear Models. London, UK: Chapman & Hall 1989.
19. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19: 335-351.
20. Pastor-Barriuso R, Guallar E, Coresh J. Transition models for change-point estimation in logistic regression. Stat Med 2003; 22: 1141-1162.
21. Pollan M, Pastor-Barriuso R, Ardanaz E et al. Recent Changes in Breast Cancer Incidence in Spain, 1980-2004. J Natl Cancer Inst 2009; 101: 1584-1591.
22. Eltom MA, Jemal A, Mbulaiteye SM et al. Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst 2002; 94: 1204-1210.
23. Saltzstein SL. Pulmonary malignant lymphomas and pseudolymphomas classification, therapy and prognosis. Cancer 1963; 16: 928-955.
24. Lázaro P. Evaluación de Servicios Sanitarios: La alta Tecnologia Mé dica en España. Madrid, Spain: Fondo de Investigación Sanitaria 1990.
25. Galceran J, Marcos-Gragera R, Soler M et al. Cancer incidence in AIDS patients in Catalonia, Spain. Eur J Cancer 2007; 43: 1085-1091.
26. Izarzugaza MI, Steliarova-Foucher E, Martos MC, Zivkovic S. Non-Hodgkin's lymphoma incidence and survival in European children and adolescents (1978-1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006; 42: 2050-2063.
27. Collier AC, Coombs RW, Schoenfeld DA et al. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group. N Engl J Med 1996; 334: 1011-1017.
28. Moore RD, Chaisson RE. Natural history of HIV infection in the era of combination antiretroviral therapy. AIDS 1999; 13: 1933-1942.
29. Castilla J, Pollan M, Lopez-Abente G. The AIDS epidemic among Spanish drug users: a birth cohort-associated phenomenon. Am J Public Health 1997; 87: 770-774.
30. Marcos-Gragera R, Guma J, de Sanjose S. Analysis of cancer incidence, survival and mortality according to the main tumoral localizations, 1985-2019: non-Hodgkinian lymphomas. Med Clin (Barc) 2008; 131 Suppl 1: 72-77.
31. Fritschi L, Benke G, Hughes AM et al. Occupational exposure to pesticides and risk of non-Hodgkin's lymphoma. Am J Epidemiol 2005; 162: 849-857.
32. Porta M, Puigdomenech E, Ballester F et al. [Studies conducted in Spain on concentrations in humans of persistent toxic compounds]. Gac Sanit 2008; 22: 248-266.
33. Harris NL, Jaffe ES, Diebold J et al. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Ann Oncol 1999; 10: 1419-1432.
34. Harris NL, Jaffe ES, Diebold J et al. Lymphoma classification-from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms. Ann Oncol 2000; 11 Suppl 1: 3-10.
35. Marcos-Gragera R, Vilardell L, Izquierdo A et al. Population-based incidence of lymphoid neoplasms by histological subtypes in Girona (Spain), 1994-2001. Med Clin (Barc) 2006; 126: 5-12.
36. Morton LM, Wang SS, Devesa SS et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 2006; 107: 265-276.
37. Herrinton LJ. Epidemiology of the Revised European-American Lymphoma Classification subtypes. Epidemiol Rev 1998; 20: 187-203.
38. Groves FD, Linet MS, Travis LB, Devesa SS. Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst 2000; 92: 1240-1251.